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Structuralmass spectrometrywith its various techniques is a powerful tool for the structural elucidation ofmedical-
ly relevant protein assemblies. It delivers information on the composition, stoichiometries, interactions and topolo-
gies of these assemblies. Most importantly it can deal with heterogeneous mixtures and assemblies which makes it
universal among the conventional structural techniques. In this review we summarise recent advances and chal-
lenges in structural mass spectrometric techniques. We describe how the combination of the different mass spec-
trometry-based methods with computational strategies enable structural models at molecular levels of resolution.
These models hold signiﬁcant potential for helping us in characterizing the function of protein assemblies related
to human health and disease.
Signiﬁcance: In this reviewwe summarise the techniques of structuralmass spectrometry often appliedwhen study-
ing protein-ligand complexes. We exemplify these techniques through recent examples from literature that helped
in the understanding of medically relevant protein assemblies. We further provide a detailed introduction into var-
ious computational approaches that can be integrated with these mass spectrometric techniques. Last but not least
we discuss case studies that integrated mass spectrometry and computational modelling approaches and yielded
models of medically important protein assembly states such as ﬁbrils and amyloids.
© 2017 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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1. Introduction
Proteins are key players in life executing critical tasks for cellular
functions. These functions are often linkedwith their structural arrange-
ments as well as their dynamic interactions with ligands such as pro-
teins/peptides, nucleotides, carbohydrates or lipids. The structural
analysis of proteins and the complexes they formwith their interaction
partners is therefore of paramount importance. Recent improvements
in mass spectrometry made it an ideal tool for the structural analysis
of proteins and their ligands [1–5]. It delivers information on the com-
position, stoichiometries, protein interactions and interaction networks
aswell as ligand binding [6]. There is a variety of techniques linkedwith
mass spectrometry including proteomics, (chemical or UV) cross-
linking, labelling techniques (such as hydrogen/deuterium-exchange)
or mass spectrometry of intact protein assemblies, the latter is often
coupled with ion mobility (IM) spectroscopy (see Table 1) [6].
Mass spectrometric techniques target either the peptides produced
by hydrolysis of the proteins using proteases (i.e. bottom-up ap-
proaches) or the intact proteins. The latter distinguishes between top-
down proteomics, i.e. the fragmentation of the intact proteins during
analysis, or the analysis of the intact proteins using “native”mass spec-
trometry [7]. The advantage of bottom-up approaches is the opportuni-
ty to unambiguously identify speciﬁc sites such as modiﬁed amino acid
residues (proteomics) or binary interaction sites (cross-linking). A top-
down approach, on the other hand, allows the quantitative determina-
tion of these sites in the same experiment. Native mass spectrometry
determines protein complex' stoichiometries along with protein inter-
actions and speciﬁcity of the ligands.
As the structure of a protein-ligand complex is directly linked with
function, its malfunction is just as dependent. Nowadays mass spec-
trometry is playing an important role in structure elucidation of phar-
maceutically relevant proteins as well as drug binding [8]. However,
the information obtained from the various mass spectrometric tech-
niques often yields low-resolution structures. One way to increase the
degree of resolution and gain information unattainable by a single
method is to bring together the information derived from various tech-
niques [9,10]. This has prompted researchers to develop computational
tools and methods that allowed encoding structural information
derived from various mass spectrometry-based experiments (as well
as other techniques) into diverse sets of modelling restraints, i.e. estab-
lishing integrative modelling [11,12]. The integration of these restraints
into sophisticated algorithms for 3D model generation enabled
determining the structure and in many cases the conformational dy-
namics of proteins and their complexes [11]. The wealth of computa-
tional tools and algorithms for structure-based prediction are
exempliﬁed by homology modelling [13], and docking strategies [14],
for instance in drug discovery [15] or techniques such as molecular dy-
namics simulations [16] and de novo modelling.
In this review we summarise the advances of structural mass spec-
trometry in the study of protein-ligand complexes. We exemplify the
different techniques through recent examples from literature that
helped in the understanding of medically relevant protein assemblies.
We further provide a detailed introduction into various computational
approaches that can be used to bring together the information from
the variousmass spectrometric techniques. Last but not least we discuss
case studies that integrated mass spectrometry and computational
modelling approaches and yielded models of medically important pro-
tein assembly states such as ﬁbrils and amyloids.
2. Structural mass spectrometry
2.1. Proteomics reveals changes in protein expression and post-translation-
al modiﬁcations
The proteome is the entire set of proteins in a cell, an organism or a
tissue at a deﬁned time point and under deﬁned conditions [17]. Prote-
omics, consequently, is the large-scale study of the proteome and now-
adays mostly involves mass spectrometry-based protein identiﬁcation
[18–21]. For this, proteins are usually hydrolysed using speciﬁc
endoproteinases. The speciﬁc peptide mixture is then analysed in a
mass spectrometer. Peptide and fragmentmasses lead to the identiﬁca-
tion of the protein(s) after database searching [22]. Depending on the
sample complexity separation techniques on the peptide or protein
level are included in theproteomicsworkﬂow [23–25]. Recent improve-
ments in mass spectrometry enabled the identiﬁcation of post-transla-
tional modiﬁcations [26,27] and relative or absolute quantiﬁcation of
proteins [28,29] on a routine basis. Notably, entire proteomes can now-
adays be explored in very short time spans [30,31]. As such several
proteomes and their interactomes have been described to a high
standard. Examples include the studies on Saccharomyces cerevisiae
[32–34], Drosophila melanogaster [35,36] and even humans [37–39].
Of the available techniques, quantitative mass spectrometry plays a
major role in clinical proteomics [40–42]. In particular, the quantiﬁca-
tion of post-translational modiﬁcations, which are the regulatory
Table 1
Overview on MS techniques discussed in this review. The principle, experimental workﬂows, commonly used instrumentation, limitations as well as the outcome are given for each
technique.
MS technique Principle Experimental procedure Instrumentation Limitations Outcome
Proteomics Identiﬁcation of proteins
by
fragmentation/sequencing
of peptides
(i) Digestion of proteins, (ii) LC-MS/MS of
peptides, (iii) database searching
High speed, high
sensitivity mass
spectrometers (mostly
Orbitrap, Q-Tof or Q-Trap
instruments)
Protein interactions only
identiﬁed indirectly
Identiﬁcation of proteins and
post-translational
modiﬁcations; quantiﬁcation;
interactomes
Cross-linking Identiﬁcation of binary
protein interactions by
fragmentation/sequencing
of cross-linked
di-peptides
(i) Cross-linking of proteins, (ii) digestion
of proteins, (iii) LC-MS/MS of peptides, (iv)
identiﬁcation of cross-linked di-peptides
by specialised software; (*) optional
pre-fractionation of proteins or peptides
High sensitivity, high
resolution mass
spectrometers (mostly
Orbitrap instruments)
Only binary interactions;
cross-linking yield
dependent on protein
sequence and
cross-linking chemistry
Identiﬁcation of protein
interactions; protein
networks; distance restraints
H/D-X Exchange of backbone
protons by deuterium to
study solvent accessibility
(i) Exchange of protons by deuterium, (ii)
analysis of intact proteins or peptides after
digestion, (iii) increase/decrease of
protein/peptide masses, (iv) structural
analysis of changes in H/D-X (peptides)
Mostly Q-ToF
instruments; in some
cases automated
procedure using
pipetting robots
Back exchange of
deuterium; structural
information of protein
required; data analysis
difﬁcult
Solvent accessibility;
structural changes/dynamics;
ligand binding
Native
ion-mobility
MS
Transfer of intact protein
assemblies into the gas
phase of a mass
spectrometer
(i) Exchanging puriﬁcation buffer to
aqueous, volatile buffer, (ii) manual MS
analysis of protein complexes, (iii) manual
data analysis (using specialised software)
Modiﬁed instruments,
usually Q-ToF mass
spectrometers (in some
cases modiﬁed Orbitrap
instruments)
Protein complexes need
to be kept intact;
modiﬁed instruments
required; no direct
interaction sites
Identiﬁcation of protein
stoichiometries and
interactions; topology; ligand
binding; collision
cross-sections; shape
restraints
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switches in the cell, gained importance [26,43]. As an example, a recent
study employed quantitative proteomics to explore B-cell receptor sig-
nalling in Burkitt's lymphoma [44] which is heavily dependent on pro-
tein phosphorylation [45]. A comprehensive proteomic analysis of
Burkitt's lymphoma model cell lines revealed the phosphorylation sta-
tus of several hundred effector proteins dependent on B-cell receptor
stimulation duration. Clustering analysis of phosphorylation sites eluci-
dated early and later phosphorylation events of B-cell receptor stimula-
tion. Combining this quantitative information with known protein-
protein interactions allowed generating a signalling network [44] (Fig.
1A).
2.2. Cross-linking to study binary protein interactions
Another experimental way to study protein networks and interac-
tions is chemical or UV cross-linking. This involves the use of chemical
or UV-activatable reagents which are reactive towards functional
groups of the protein in close proximity [46,47]. Cross-linking thus gen-
erates covalent linkageswithin a protein or a protein complex leading to
distance restraints which can be used in computational modelling ap-
proaches [48,49]. The identiﬁcation of cross-links, however, is not trivi-
al. After digestion with endoproteinases, the generated peptide mixture
includes linear peptides as well as cross-linked di-peptides. The latter
contain sequence stretches from disparate regions of the same or
different proteins and their identiﬁcation therefore requires specialised
software tools (e.g., xQuest [50], MassMatrix [51], StavroX [52], pLink
[53]).
The structure of a protein or the complexes it forms is related to
function. Over the last decade the various cross-linking strategies
helped in the successful structural elucidation of many protein as-
semblies [3]. In combination with cryo-electron microscopy, cross-
linking allowed generating high-resolution structures of large pro-
tein machineries [54–57]. Likewise, cross-linking helped in elucidat-
ingmedically relevant protein assemblies. A recent study used cross-
linking to monitor the conformational states of the peroxisome
proliferator-activated receptor-β/δ, which is involved in type 2 dia-
betes, lipid disorder and metabolic syndrome [58–60]. Employing
various cross-linking reagents as well as incorporating a photo-reac-
tive amino acid revealed stabilisation of a ligand-bound conforma-
tion [61] (Fig. 1B).
2.3. Hydrogen-deuterium-exchange to study ligand binding and dynamics
A powerfulway to study ligand binding to proteins classiﬁed as drug
targets is bymonitoring the exchange of labile protons for bulk deuteri-
um in solution. This is commonly used in hydrogen-deuterium-ex-
change (H/D-X) where amide protons of the protein backbones are
exchanged by deuterium in aqueous D2O-containing buffers [62,63].
The uptake of deuteriumdepends on temperature and pH aswell as sol-
vent accessibility andhydrogen bondingof the amide protons; the latter
two are indicators of protein conformational changes. Global analysis of
Fig. 1. Various mass spectrometric techniques reveal information on protein complexes and assemblies. (A) Quantitative phosphoproteomics identiﬁed novel B-cell antigen receptor
(BCRs) in Burkitt's lymphoma. The signalling network shows selected BCRs. Proteins were grouped according to their interactions. Phosphosites are indicated for each gene. The
phosphorylation status is given for different stimulation times. The relative ratio for each phosphosite (SILAC ratio) is colour coded. Adapted from [44]. (B) Photo-cross-linking of
PPAR-β/δ reveals conformational changes upon ligand binding. The ligand binding domain of PPAR-β/δ is shown. Amino acids replaced by Bpa are shown in green. The mass spectrum
shows a photo-cross-link between F180Bpa and Ile-379. Adapted from [61]. (C) Binding of HIV inhibitors to ZMPSTE24 studied by mass spectrometry. A high resolution mass
spectrum uncovered binding of CHS detergent (blue), OGNG detergent (green), Lopinavir (black) and Ritonavir (red). Binding of Darunavir could not be observed. Adapted from [83].
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the intact proteins usually involves differential comparison of protein
conformations (e.g. bound versus unbound states). Digestion of the la-
belled proteins provides structural insights into particular sites of the
proteins and their ability to exchange protons. As the exchange reaction
is usually quenched at lowpH (b2.5) pepsin is the enzymeof choice [62,
63]. Comparing the time-dependent deuterium uptake of a protein
under different condition gives rise to changes in solvent accessibility
for example upon folding of a protein [64] or binding of a ligand [65].
Encoding such information intomodelling restraints enables generating
three-dimensional models of native protein assemblies.
Due to its ability to directly reﬂect conformational changes and dy-
namics, H/D-X has been employed in many studies to investigate
drug/ligand binding. A recent example is allosteric inhibition of MCL-
1, a major pathologic factor in human cancer [66]. MCL-1 is an anti-ap-
optotic BCL-2 family protein binding to pro-apoptotic BCL-2 proteins
through a surface groove thus preventing apoptosis of cancer cells. H/
D-X and mass spectrometry helped elucidating an allosteric inhibition
mechanism of MCL-1 by covalent modiﬁcation through a small mole-
cule [67]. Binding of MAIM1 (MCL-2 allosteric inhibition molecule 1)
at an allosteric site causes conformational changes in MCL-2 and pre-
vents binding of pro-apoptotic proteins [67].
2.4. Native ion mobility-mass spectrometry reveals shape and topology of
protein assemblies
A versatile application in structural mass spectrometry is the analy-
sis of intact protein complexes, a technique often called “native mass
spectrometry”. It reveals protein interactions, stoichiometries, ligand
binding and, in combination with IM, gives insights into the topology
of the protein assemblies [68–70]. There are two pre-requisites, howev-
er: First, the protein assemblies have to be kept intact in the analysis
buffer; contrary to the conventionally used organic solvents these are
typically volatile, aqueous buffers. Second, the non-covalent protein in-
teractions have to bemaintained during analysis in the gas phase of the
mass spectrometer. The latter is achieved by several instrumentmodiﬁ-
cations mostly involving changes in the pressure to allow desolvation
and gentle transfer of the macromolecules into the gas phase by colli-
sional cooling [71]. In most cases, collisional induced dissociation
(CID) is applied to strip subunits off intact protein assemblies, however,
additional instrument modiﬁcations allow fragmentation by surface in-
duced dissociation (SID) [72], infrared laser radiation [73], ultraviolet
photodissociation (UVPD) [74,75] and electron transfer dissociation
(ETD) [76] - all deliver complementary information on the structural ar-
rangements. In this way, many intact protein assemblies including ribo-
somes [77], viruses [78,79], ATP synthases [80,81] were successfully
studied and their stoichiometries and in some cases conformations
were determined. For both, native MS and native IM-MS experiments,
specialised software was developed to facilitate data analysis. These in-
clude Massign [82] and Unidec [83], which allow the determination of
protein stoichiometries in heterogeneous assemblies and PULSAR [84]
or Amphitrite [85] that enable the analysis of IM data including calcula-
tion of collisional cross sections. Further improvements in native MS
also allowed the analysis of membrane protein complexes maintaining
their interactions with lipids [86–88].
Manymembrane proteins are drug targets and consequently are the
key players during various disease. A recent study employed high reso-
lution native mass spectrometry to unravel binding of HIV protease in-
hibitors, metal ions and detergents to human zinc protease ZMPSTE24.
ZMPSTE24 is involved in processing of lamin A, which is one of the
major components of nuclear lamina [89]. ZMPSTE24 deﬁciency causes
progeroid syndromes, whichmimic physiological aging [90]. Mass spec-
trometry enabled monitoring cleavage of prelamin A in real-time and,
furthermore, showed that ZMSTE24 protease activity was inhibited by
HIV inhibitors revealing unknown side-effects of HIV drugs [91]. An ex-
ample spectrum of HIV drug binding is shown in Fig. 1C.
3. Computational modelling techniques
3.1. Restraint-guided computational modelling
Computational strategies have emerged as invaluable tools for
interpreting the structural and dynamic information extracted from
complementary mass spectrometric techniques. The power of such
methods lies in their ability to bring together information that other-
wisewill be reported independently. Typically, they involve twodistinct
but nonetheless related steps: a) sampling the protein or protein assem-
bly conﬁgurations and, b) analysing the models generated. In the ﬁrst
step a search of protein conﬁgurational space is performed using
established statistical averaging algorithms, i.e.Monte Carlo simulations
and/or molecular dynamics (MD) such as replica-exchange MD. De-
pending on the structural information available, the proteins are repre-
sented by either low (e.g. coarse-grain, molecular envelopes or 2D
images) or high-resolution structures (e.g. crystal or NMR structures,
homology models), while in the cases of protein complex architectures
hybrid representations can be employed [12]. These conﬁgurations are
subjected to search for “good” structural models, guided by modelling
restraints generated from the relevant experiments [92]. Such restraints
can either be directly incorporated into the sampling algorithms by
employing a scoring function [12,92] or used to ﬁlter structural models
generated by computational methods [93,94]. Overall, the advantage of
the ﬁrst approach is that it can simultaneously integrate multiple types
of restraints and as such tominimize the time required for downstream
data analysis. The search will further be guided towards regions of the
search space being more likely to be relevant. On the other hand, the
second approach can yield structural models corresponding to the dif-
ferent restraints used without the need to repeat the sampling experi-
ments. In either case the resulting model structures should match the
input data and as such it would reﬂect the data used to generate
them. For the purpose of this review we assume a modelling workﬂow
that follows the ﬁrst approach.
3.2. Ensemble analysis
Having generated the models matching the input experimental in-
formation, the second step of the integrative modelling workﬂow in-
volves the data analysis and their subsequent interpretation. Ideally
this should involve an iterative process where the structural models
built are used to judge whether or not the experimental data are sufﬁ-
cient to guide us towards unambiguous solutions. It is therefore expect-
ed that in cases where the experimental information available are
insufﬁcient to yield credible model(s), additional experiments from
the same or a different method are required. As such the data analysis
and interpretation usually involves a model reﬁnement step as well as
computational algorithms to evaluate the distinctiveness of the solu-
tions. The ﬁrst allows enhancing the accuracy of the outputs by increas-
ing the quality-of-ﬁt between the models and the input data, while the
second provides a measure of the precision of the method. In case of
mass spectrometry-based integration, for which benchmark studies
have shown that the accuracy of computational predictions is generally
enhancedwith increased amount of data used [12], it is often difﬁcult to
determine the level of accuracy one would expect from the various
datasets. This is often depending on the nature of the system studied
and the type of mass spectrometric methods used. For instance, rela-
tively high resolution cross-linking MS methods have scored high
with respect to the accuracy of 3D structural predictions in relevant
benchmarking exercises [48,95]. On the other handwhile lower resolu-
tion restraints such as subunit connectivity (native MS) [12], CCS (IM-
MS) [96] and solvent accessibilities (covalent labelling MS) [9] exhibit
limited predictability, their computational integration allowedmore ac-
curate predictions demonstrating the power of integrative modelling
strategies. Overall a current challenge in the ﬁeld is the development
of integrative mass spectrometry-based workﬂows for generating
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accurate three-dimensional models representing the optimal ﬁt to the
experiments.
3.3. Scoring structural models against multiple experimental data
Despite the advantages of the integrative modelling and docking
strategies, they usually require careful handling of data uncertainties
(e.g. false positives, errors) and of incomplete or heterogeneous infor-
mation. To account for these, a Bayesian scoring function for guiding
the sampling of protein conﬁgurational space can be followed. Such
scoring function brings together the individual restraints by simulta-
neously accounting for a parameter that describes data uncertainties
and/or heterogeneities. It is worth noting that careful consideration
should be given when using a weighing function for the integration of
restraints from diverse and heterogeneous sources. Weighting the indi-
vidual terms is largely depending on the completeness, quality and
amount of data obtained and may be subject of thorough analysis
using known structures [48]. The scoring function ﬁnds the likelihood
of a model structure given the input restraints derived from the various
experiments [9,97]. Within this approach, a restraint can be expressed
as amodelling feature (e.g. solvent accessibility, time-dependent uptake
of deuterium, change in collision cross-section, ATD) quantiﬁedwith re-
spect to the data used to deﬁne it. A fully satisﬁed restraint can take a
value of 0, while violations of all restraints would result to a value of 1
[96,98]. Themost likely structuralmodel will be themodel that exhibits
the least violation of restraints given the probability distribution.
3.4. Software tools for integrative modelling
Multi-scale software tools that enable integrativemodelling of protein
complex assembly and dynamics are the Integrative Modelling Platform
[92] and HADDOCK [99], while docking algorithms based on geometric
complementarity and energy considerations include for instance
PatchDock [100] or Firedock [101]. Individual software modules and
packages have so far used different mass spectrometric techniques to in-
form protein complex modelling. These include ion mobility [94,96], na-
tive MS [12], cross-linking MS [48,97,102,103], covalent labelling MS [9]
and HDX [104] as well as the integration of MS-based techniques with
EM [105] and NMR [93]. Computational modelling of heterogeneous
datasets, includingMS-based techniques, has been exempliﬁed in partic-
ularly large and dynamic assemblies such as the nuclear pore complex
[98], the eIF1:eIF3 translation initiation complex [106], the proteasome
[48,103], amyloidogenic proteins [107–109] and the ATP synthase [81].
3.5. Modelling protein assembly dynamics
Despite all these noteworthy progresses, most of these tools are
making predictions of static models without taking into account
Fig. 2.Modellingworkﬂow to generate structuralmodels of β2-microglobulin oligomers. Variousmass spectrometric techniqueswere employed to gain information on stoichiometry and
topology (native MS), shape and ﬂexibility (IM-MS) and protein-protein interactions (cross-linking). These results were converted into structural restraints which were integrated with
structures from X-ray crystallography or EM. The generated models were analysed by ﬁtting structural restraints into the available structures.
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small or large scale conformational changes of proteins and their
complexes. This is more problematic for the case where slow confor-
mational changes occur which require signiﬁcant amount of compu-
tational resources. As such a current challenge in the integrative
modelling strategies is the development of tools that can monitor
protein dynamics at time-scales comparable to experiments [110].
This becomes pertinent with the recent developments in comple-
mentary MS-based techniques targeting protein dynamics such as
HDX-MS [111,112]. The development of both the experimental MS-
based methods and the computational algorithms for structural
analysis holds great promise for enabling keen scientists to study
the conformational states of large protein complexes, information
that is often challenging to achieve using conventional strategies.
Of note it is the potential of such tools to probe binding interfaces be-
tween protein and small molecules. As a consequence, it will allow
researchers to generate testable hypotheses for the function of
large protein complexes in the cell.
4. Integrating structural mass spectrometry and computational
modelling - application examples
4.1. Early assembly mechanism for amyloidogenic β2-microglobulin re-
vealed by cross-linking and native mass spectrometry
A recent study highlighted the combination of mass spectrometry-
based methods with integrative modelling and MD simulations for ex-
amining the mechanism of oligomer formation in β2-microglobulin
[107]. β2-Microglobulin forms oligomers, which can aggregate into am-
yloid ﬁbrils with serious clinical consequences (e.g. [113]). By combin-
ing native, ion mobility and chemical cross-linking MS through a
modelling strategy, an early assembly pathway for this important pro-
tein was proposed. In particular, native MS allowed the identiﬁcation
of early oligomeric intermediates ranging from monomer to tetramer,
while IM-MS provided structural information that enabled shape re-
straints for interrogating computer-generated structures. This together
with distance restraints from chemical cross-linking MS and by inte-
grating with existing data from traditional structural techniques such
as X-ray crystallography, NMR spectroscopy and electron microscopy,
informed a modelling workﬂow (Fig. 2). In this workﬂow, a multi-
scale modelling strategy was adopted comprising the use of a scoring
function to bring together the data from various mass spectrometry-
based sources and in vacuummolecular dynamics simulations to inter-
rogate gas-phase model structures. This enabled the proposal of a
step-wise assembly mechanism with domain-swapping for β2-micro-
globulin that may precede ﬁbril formation [107]. Overall, the hybrid
mass spectrometry approach used in this study demonstrated the
power of combined experimental and computational workﬂow for un-
derstanding clinically relevant protein complexes that are often chal-
lenging targets in structural biology.
4.2. Insulin ﬁbrillation examined by ion mobility mass spectrometry and
molecular modelling
Insulin is a peptide hormone which forms ﬁbrils under
amyloidogenic conditions. A recent study investigated early oligo-
mers of insulin preceding ﬁbril growth by combining IM-MS with
molecular modelling [114]. While mass spectra revealed monomers
and dimers being the most abundant species, higher oligomers, up
to dodecamers, were also observed (Fig. 3A). Arrival time distribu-
tions of these oligomers obtained from IM-MS showed several con-
formations of these oligomers with the compact form in the
highest abundance. IM-MS further allowed calculation of collision
cross-sections of the oligomers.
The collisional cross-section and charge states obtained for dimeric
insulin agreed well with the available crystal structure and the calculat-
ed net charge. The dimer was therefore split into two monomers (3+
Fig. 3. Oligomerisation of insulin followed by IM-MS and molecular modelling. (A) Mass spectra of early oligomers reveal monomeric and dimeric insulin as the most abundant species
(upper panel). Oligomers up to dodecamers were also observed (lower panel). (B) A novel assembly mechanism based on experimental data was proposed. The dimer forms the core
unit in the higher aggregates.
Adapted from [106].
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and 4+ species) which were subjected to molecular dynamics simula-
tions. Various conformations of the two monomers were observed and
employed in protein docking to produce a dimer which was then sub-
jected to MD simulations. Docking of the compact monomers yielded
conformations of the compact dimers, while docking the extended
monomers yielded the extended dimers. This approach allowed gener-
ation of the conformational family observed experimentally. Investigat-
ing the contact interface and stability of the dimers revealed that
hydrophobic interactions are fundamental in the oligomerisation pro-
cess. Comparing the results froma previous study [115]with the obtain-
ed collisional cross sections and oligomeric species obtained suggest a
novel assembly mechanism in which the dimeric species may be the
core stacking species in larger aggregates (Fig. 3B).
5. Conclusions
We reviewed the emerging role of integrativemass spectrometry for
predicting structuralmodels ofmacromolecular assemblies. Overall, the
future of structural mass spectrometry is hybrid and encapsulates the
use of diverse methods for understanding the workings of biologically
and medically relevant systems. We anticipate that the continuing de-
velopment of mass spectrometry-based hybridmethodologies will con-
tribute to consolidating the critical role of structural mass spectrometry
in structural biology and will enable tackling challenges and limitations
mainly associated with heterogeneity and dynamics currently frustrat-
ing individual approaches.
Conﬂict of interest
The authors declare that they have no conﬂicts of interests.
Acknowledgements
We thank Jasmin Corso, Henning Urlaub (both MPI for Biophysical
Chemistry, Göttingen), Thomas Oellerich (Johann Wolfgang Goethe
University Frankfurt), Rico Schwarz, Andrea Sinz (both Martin Luther
University Halle-Wittenberg), Shahid Mehmood, Carol Robinson (both
University of Oxford) and Perdita Barran (University of Manchester)
for providing mass spectra and ﬁgures. A.P. acknowledges funding from
the Wellcome Trust (109854/Z/15/z). C.S. acknowledges funding from
the FederalMinistry of Education and Research (BMBF, ZIK programme;
03Z22HN22), the European Regional Development Fund (EFRE; ZS/
2016/04/78115) and the MLU Halle-Wittenberg.
References
[1] R. Aebersold, M. Mann, Mass-spectrometric exploration of proteome structure and
function, Nature 537 (7620) (2016) 347–355.
[2] M. Landreh, et al., A sliding selectivity scale for lipid binding tomembrane proteins,
Curr. Opin. Struct. Biol. 39 (2016) 54–60.
[3] A. Leitner, et al., Crosslinking and mass spectrometry: an integrated technology to
understand the structure and function ofmolecular machines, Trends Biochem. Sci.
41 (1) (2016) 20–32.
[4] I. Liko, et al., Mass spectrometry guided structural biology, Curr. Opin. Struct. Biol.
40 (2016) 136–144.
[5] C. Schmidt, K. Kramer, H. Urlaub, Investigation of protein-RNA interactions bymass
spectrometry–techniques and applications, J. Proteome 75 (12) (2012)
3478–3494.
[6] C. Schmidt, C.V. Robinson, Dynamic protein ligand interactions–insights from MS,
FEBS J. 281 (8) (2014) 1950–1964.
[7] A.D. Catherman, O.S. Skinner, N.L. Kelleher, Top down proteomics: facts and per-
spectives, Biochem. Biophys. Res. Commun. 445 (4) (2014) 683–693.
[8] U. Leurs, U.H. Mistarz, K.D. Rand, Getting to the core of protein pharmaceuticals–
comprehensive structure analysis by mass spectrometry, Eur. J. Pharm. Biopharm.
93 (2015) 95–109.
[9] C. Schmidt, et al., Surface accessibility and dynamics of macromolecular assemblies
probed by covalent labeling mass spectrometry and integrative modeling, Anal.
Chem. 89 (3) (2017) 1459–1468.
[10] A. Sinz, et al., Chemical cross-linking and native mass spectrometry: a fruitful com-
bination for structural biology, Protein Sci. 24 (8) (2015) 1193–1209.
[11] K. Lasker, et al., Integrative structure modeling of macromolecular assemblies from
proteomics data, Mol. Cell. Proteomics 9 (8) (2010) 1689–1702.
[12] A. Politis, et al., Topological models of heteromeric protein assemblies from mass
spectrometry: application to the yeast eIF3:eIF5 complex, Chem. Biol. 22 (1)
(2015) 117–128.
[13] A. Sali, T.L. Blundell, Comparative protein modelling by satisfaction of spatial re-
straints, J. Mol. Biol. 234 (3) (1993) 779–815.
[14] M.M. Gromiha, K. Yugandhar, S. Jemimah, Protein–protein interactions: scoring
schemes and binding afﬁnity, Curr. Opin. Struct. Biol. 44 (2017) 31–38.
[15] A. Schlessinger, et al., Structure-based discovery of prescription drugs that interact
with the norepinephrine transporter, NET, Proc. Natl. Acad. Sci. U. S. A. 108 (38)
(2011) 15810–15815.
[16] A. Hospital, et al., Molecular dynamics simulations: advances and applications, Adv.
Appl. Bioinforma. Chem. 8 (2015) 37–47.
[17] M.R. Wilkins, et al., Progress with proteome projects: why all proteins expressed
by a genome should be identiﬁed and how to do it, Biotechnol. Genet. Eng. Rev.
13 (1996) 19–50.
[18] C.H. Ahrens, et al., Generating and navigating proteome maps using mass spec-
trometry, Nat. Rev. Mol. Cell Biol. 11 (11) (2010) 789–801.
[19] X. Han, A. Aslanian, J.R. Yates 3rd, Mass spectrometry for proteomics, Curr. Opin.
Chem. Biol. 12 (5) (2008) 483–490.
[20] M. Mann, R.C. Hendrickson, A. Pandey, Analysis of proteins and proteomes bymass
spectrometry, Annu. Rev. Biochem. 70 (2001) 437–473.
[21] T.C. Walther, M. Mann, Mass spectrometry-based proteomics in cell biology, J. Cell
Biol. 190 (4) (2010) 491–500.
[22] H. Steen, M.Mann, The ABC's (and XYZ's) of peptide sequencing, Nat. Rev. Mol. Cell
Biol. 5 (9) (2004) 699–711.
[23] S. Camerini, P. Mauri, The role of protein and peptide separation before mass spec-
trometry analysis in clinical proteomics, J. Chromatogr. A 1381 (2015) 1–12.
[24] A. Motoyama, J.R. Yates 3rd, Multidimensional LC separations in shotgun proteo-
mics, Anal. Chem. 80 (19) (2008) 7187–7193.
[25] T. Stasyk, L.A. Huber, Zooming in: fractionation strategies in proteomics, Proteo-
mics 4 (12) (2004) 3704–3716.
[26] J.V. Olsen, M. Mann, Status of large-scale analysis of post-translational modi-
ﬁcations by mass spectrometry, Mol. Cell. Proteomics 12 (12) (2013)
3444–3452.
[27] Y. Zhao, O.N. Jensen, Modiﬁcation-speciﬁc proteomics: strategies for characteriza-
tion of post-translational modiﬁcations using enrichment techniques, Proteomics 9
(20) (2009) 4632–4641.
[28] M. Bantscheff, et al., Quantitative mass spectrometry in proteomics: critical re-
view update from 2007 to the present, Anal. Bioanal. Chem. 404 (4) (2012)
939–965.
[29] M. Bantscheff, et al., Quantitative mass spectrometry in proteomics: a critical re-
view, Anal. Bioanal. Chem. 389 (4) (2007) 1017–1031.
[30] S. Beck, et al., The impact II, a very high-resolution quadrupole time-of-ﬂight in-
strument (QTOF) for deep shotgun proteomics, Mol. Cell. Proteomics 14 (7)
(2015) 2014–2029.
[31] M. Mann, et al., The coming age of complete, accurate, and ubiquitous proteomes,
Mol. Cell 49 (4) (2013) 583–590.
[32] L.M. de Godoy, et al., Status of complete proteome analysis by mass spectrometry:
SILAC labeled yeast as a model system, Genome Biol. 7 (6) (2006) R50.
[33] A.C. Gavin, et al., Proteome survey reveals modularity of the yeast cell machinery,
Nature 440 (7084) (2006) 631–636.
[34] N.J. Krogan, et al., Global landscape of protein complexes in the yeast Saccharomy-
ces cerevisiae, Nature 440 (7084) (2006) 637–643.
[35] E. Brunner, et al., A high-quality catalog of the Drosophila melanogaster proteome,
Nat. Biotechnol. 25 (5) (2007) 576–583.
[36] K.G. Guruharsha, et al., A protein complex network of Drosophila melanogaster, Cell
147 (3) (2011) 690–703.
[37] R.M. Ewing, et al., Large-scale mapping of human protein-protein interactions by
mass spectrometry, Mol. Syst. Biol. 3 (2007) 89.
[38] M.S. Kim, et al., A draft map of the human proteome, Nature 509 (7502) (2014)
575–581.
[39] M. Wilhelm, et al., Mass-spectrometry-based draft of the human proteome, Nature
509 (7502) (2014) 582–587.
[40] Y. Liu, et al., Mass spectrometric protein maps for biomarker discovery and clinical
research, Expert. Rev. Mol. Diagn. 13 (8) (2013) 811–825.
[41] M. Palmblad, A. Tiss, R. Cramer, Mass spectrometry in clinical proteomics - from
the present to the future, Proteomics Clin. Appl. 3 (1) (2009) 6–17.
[42] C.E. Parker, et al., Mass-spectrometry-based clinical proteomics–a review and pro-
spective, Analyst 135 (8) (2010) 1830–1838.
[43] C. Choudhary, M. Mann, Decoding signalling networks by mass spectrometry-
based proteomics, Nat. Rev. Mol. Cell Biol. 11 (6) (2010) 427–439.
[44] J. Corso, et al., Elucidation of tonic and activated B-cell receptor signaling in
Burkitt's lymphoma provides insights into regulation of cell survival, Proc. Natl.
Acad. Sci. U. S. A. 113 (20) (2016) 5688–5693.
[45] T. Kurosaki, Regulation of BCR signaling, Mol. Immunol. 48 (11) (2011)
1287–1291.
[46] J. Rappsilber, The beginning of a beautiful friendship: cross-linking/mass spectrom-
etry and modelling of proteins and multi-protein complexes, J. Struct. Biol. 173 (3)
(2011) 530–540.
[47] A. Sinz, Chemical cross-linking and mass spectrometry to map three-dimensional
protein structures and protein-protein interactions, Mass Spectrom. Rev. 25 (4)
(2006) 663–682.
[48] A. Politis, et al., A mass spectrometry-based hybrid method for structural modeling
of protein complexes, Nat. Methods 11 (4) (2014) 403–406.
7A. Politis, C. Schmidt / Journal of Proteomics xxx (2017) xxx–xxx
Please cite this article as: A. Politis, C. Schmidt, Structural characterisation of medically relevant protein assemblies by integrating mass
spectrometry with computational modelling, J Prot (2017), http://dx.doi.org/10.1016/j.jprot.2017.04.019
[49] M. Schneider, et al., Blind testing of cross-linking/mass spectrometry hybrid
methods in CASP11, Proteins 84 (Suppl. 1) (2016) 152–163.
[50] O. Rinner, et al., Identiﬁcation of cross-linked peptides from large sequence data-
bases, Nat. Methods 5 (4) (2008) 315–318.
[51] H. Xu, et al., Database search algorithm for identiﬁcation of intact cross-links in
proteins and peptides using tandem mass spectrometry, J. Proteome Res. 9 (7)
(2010) 3384–3393.
[52] M. Gotze, et al., StavroX–a software for analyzing crosslinked products in protein
interaction studies, J. Am. Soc. Mass Spectrom. 23 (1) (2012) 76–87.
[53] B. Yang, et al., Identiﬁcation of cross-linked peptides from complex samples, Nat.
Methods 9 (9) (2012) 904–906.
[54] D.E. Agafonov, et al., Molecular architecture of the human U4/U6.U5 tri-snRNP, Sci-
ence 351 (6280) (2016) 1416–1420.
[55] R.G. Efremov, et al., Architecture and conformational switch mechanism of the
ryanodine receptor, Nature 517 (7532) (2015) 39–43.
[56] B.J. Greber, et al., Ribosome. The complete structure of the 55S mammalian mito-
chondrial ribosome, Science 348 (6232) (2015) 303–308.
[57] R. Rauhut, et al., Molecular architecture of the Saccharomyces cerevisiae activated
spliceosome, Science 353 (6306) (2016) 1399–1405.
[58] B. Desvergne, W. Wahli, Peroxisome proliferator-activated receptors: nuclear con-
trol of metabolism, Endocr. Rev. 20 (5) (1999) 649–688.
[59] V. Souza-Mello, Peroxisome proliferator-activated receptors as targets to treat
non-alcoholic fatty liver disease, World J. Hepatol. 7 (8) (2015) 1012–1019.
[60] B. Staels, J.C. Fruchart, Therapeutic roles of peroxisome proliferator-activated re-
ceptor agonists, Diabetes 54 (8) (2005) 2460–2470.
[61] R. Schwarz, et al., Monitoring solution structures of peroxisome proliferator-acti-
vated receptor beta/delta upon ligand binding, PLoS One 11 (3) (2016),
e0151412. .
[62] S.R. Marcsisin, J.R. Engen, Hydrogen exchange mass spectrometry: what is it and
what can it tell us? Anal. Bioanal. Chem. 397 (3) (2010) 967–972.
[63] Z. Zhang, D.L. Smith, Determination of amide hydrogen exchange by mass spec-
trometry: a new tool for protein structure elucidation, Protein Sci. 2 (4) (1993)
522–531.
[64] A. Miranker, et al., Detection of transient protein folding populations bymass spec-
trometry, Science 262 (5135) (1993) 896–900.
[65] C.V. Robinson, et al., Probing the nature of noncovalent interactions by mass spec-
trometry. A study of protein-CoA ligand binding and assembly, J. Am. Chem. Soc.
118 (1996) 8646–8653.
[66] R. Beroukhim, et al., The landscape of somatic copy-number alteration across
human cancers, Nature 463 (7283) (2010) 899–905.
[67] S. Lee, et al., Allosteric inhibition of antiapoptotic MCL-1, Nat. Struct. Mol. Biol. 23
(6) (2016) 600–607.
[68] A.J. Heck, Native mass spectrometry: a bridge between interactomics and structur-
al biology, Nat. Methods 5 (11) (2008) 927–933.
[69] S. Mehmood, T.M. Allison, C.V. Robinson, Mass spectrometry of protein complexes:
from origins to applications, Annu. Rev. Phys. Chem. 66 (2015) 453–474.
[70] M. Sharon, C.V. Robinson, The role of mass spectrometry in structure elucidation of
dynamic protein complexes, Annu. Rev. Biochem. 76 (2007) 167–193.
[71] F. Sobott, et al., A tandem mass spectrometer for improved transmission and anal-
ysis of large macromolecular assemblies, Anal. Chem. 74 (6) (2002) 1402–1407.
[72] M. Zhou, S. Dagan, V.H. Wysocki, Impact of charge state on gas-phase behaviors of
noncovalent protein complexes in collision induced dissociation and surface in-
duced dissociation, Analyst 138 (5) (2013) 1353–1362.
[73] V.A. Mikhailov, et al., Infrared laser activation of soluble and membrane protein as-
semblies in the gas phase, Anal. Chem. 88 (14) (2016) 7060–7067.
[74] D.D. Holden, J.S. Brodbelt, Ultraviolet photodissociation of native proteins follow-
ing proton transfer reactions in the gas phase, Anal. Chem. 88 (24) (2016)
12354–12362.
[75] S. Tamara, et al., Symmetry of charge partitioning in collisional and UV photon-in-
duced dissociation of protein assemblies, J. Am. Chem. Soc. 138 (34) (2016)
10860–10868.
[76] F. Lermyte, F. Sobott, Electron transfer dissociation provides higher-order structur-
al information of native and partially unfolded protein complexes, Proteomics 15
(16) (2015) 2813–2822.
[77] A.A. Rostom, et al., Detection and selective dissociation of intact ribosomes in a
mass spectrometer, Proc. Natl. Acad. Sci. U. S. A. 97 (10) (2000) 5185–5190.
[78] J. Snijder, et al., Deﬁning the stoichiometry and cargo load of viral and bacterial
nanoparticles by Orbitrap mass spectrometry, J. Am. Chem. Soc. 136 (20) (2014)
7295–7299.
[79] C. Uetrecht, et al., Stability and shape of hepatitis B virus capsids in vacuo, Angew.
Chem. Int. Ed. Eng. 47 (33) (2008) 6247–6251.
[80] C. Schmidt, et al., Comparative cross-linking and mass spectrometry of an intact F-
type ATPase suggest a role for phosphorylation, Nat. Commun. 4 (2013) 1985.
[81] M. Zhou, et al., Mass spectrometry of intact V-type ATPases reveals bound lipids
and the effects of nucleotide binding, Science 334 (6054) (2011) 380–385.
[82] N. Morgner, C.V. Robinson, Massign: an assignment strategy for maximizing infor-
mation from themass spectra of heterogeneous protein assemblies, Anal. Chem. 84
(6) (2012) 2939–2948.
[83] M.T. Marty, et al., Bayesian deconvolution of mass and ion mobility spectra: from
binary interactions to polydisperse ensembles, Anal. Chem. 87 (8) (2015)
4370–4376.
[84] T.M. Allison, et al., Quantifying the stabilizing effects of protein-ligand interactions
in the gas phase, Nat. Commun. 6 (2015) 8551.
[85] G.N. Sivalingam, et al., Amphitrite: a program for processing travelling wave ion
mobility mass spectrometry data, Int. J. Mass Spectrom. 345-347 (2013) 54–62.
[86] C. Bechara, et al., A subset of annular lipids is linked to the ﬂippase activity of an
ABC transporter, Nat. Chem. 7 (3) (2015) 255–262.
[87] K. Gupta, et al., The role of interfacial lipids in stabilizing membrane protein oligo-
mers, Nature 541 (7637) (2017) 421–424.
[88] A. Laganowsky, et al., Membrane proteins bind lipids selectively to modulate their
structure and function, Nature 510 (7503) (2014) 172–175.
[89] R.D. Goldman, et al., Nuclear lamins: building blocks of nuclear architecture, Genes
Dev. 16 (5) (2002) 533–547.
[90] M. Eriksson, et al., Recurrent de novo point mutations in lamin A cause Hutchin-
son-Gilford progeria syndrome, Nature 423 (6937) (2003) 293–298.
[91] S. Mehmood, et al., Mass spectrometry captures off-target drug binding and pro-
vides mechanistic insights into the human metalloprotease ZMPSTE24, Nat.
Chem. 8 (12) (2016) 1152–1158.
[92] D. Russel, et al., Putting the pieces together: integrative modeling platform soft-
ware for structure determination of macromolecular assemblies, PLoS Biol. 10
(1) (2012), e1001244. .
[93] A.J. Baldwin, et al., The polydispersity of alphaB-crystallin is rationalized by an
interconverting polyhedral architecture, Structure 19 (12) (2011) 1855–1863.
[94] A. Politis, et al., Integrating ion mobility mass spectrometry with molecular model-
ling to determine the architecture of multiprotein complexes, PLoS One 5 (8)
(2010), e12080. .
[95] Z. Chen, et al., Quantitative cross-linking/mass spectrometry reveals subtle protein
conformational changes, Wellcome Open Res. 1 (2016) 5.
[96] Z. Hall, A. Politis, C.V. Robinson, Structural modeling of heteromeric protein com-
plexes from disassembly pathways and ion mobility-mass spectrometry, Structure
20 (9) (2012) 1596–1609.
[97] Y. Shi, et al., A strategy for dissecting the architectures of native macromolecular
assemblies, Nat. Methods 12 (12) (2015) 1135–1138.
[98] F. Alber, et al., Integrating diverse data for structure determination of macromolec-
ular assemblies, Annu. Rev. Biochem. 77 (2008) 443–477.
[99] C. Dominguez, R. Boelens, A.M. Bonvin, HADDOCK: a protein-protein docking ap-
proach based on biochemical or biophysical information, J. Am. Chem. Soc. 125
(7) (2003) 1731–1737.
[100] D. Schneidman-Duhovny, et al., PatchDock and SymmDock: servers for rigid and
symmetric docking, Nucleic Acids Res. 33 (2005) W363–W367 (Web Server
issue).
[101] N. Andrusier, R. Nussinov, H.J. Wolfson, FireDock: fast interaction reﬁnement in
molecular docking, Proteins 69 (1) (2007) 139–159.
[102] M. Ferber, et al., Automated structure modeling of large protein assemblies using
crosslinks as distance restraints, Nat. Methods 13 (6) (2016) 515–520.
[103] K. Lasker, et al., Molecular architecture of the 26S proteasome holocomplex deter-
mined by an integrative approach, Proc. Natl. Acad. Sci. U. S. A. 109 (5) (2012)
1380–1387.
[104] D.J. Saltzberg, et al., A residue resolved Bayesian approach to quantitative interpre-
tation of hydrogen deuterium exchange from mass spectrometry: application to
characterizing protein-ligand interactions, J. Phys. Chem. B 121 (15) (2017)
3493–3501.
[105] M.T. Degiacomi, J.L. Benesch, EM intersectionIM: software for relating ion mobility
mass spectrometry and electron microscopy data, Analyst 141 (1) (2016) 70–75.
[106] J.P. Erzberger, et al., Molecular architecture of the 40SeIF1eIF3 translation initiation
complex, Cell 158 (5) (2014) 1123–1135.
[107] Z. Hall, C. Schmidt, A. Politis, Uncovering the early assembly mechanism for
amyloidogenic beta2-microglobulin using cross-linking and native mass spec-
trometry, J. Biol. Chem. 291 (9) (2016) 4626–4637.
[108] J. Seo, et al., An infrared spectroscopy approach to follow β-sheet formation in pep-
tide amyloid assemblies, Nat. Chem. 9 (1) (2017) 39–44.
[109] D.P. Smith, S.E. Radford, A.E. Ashcroft, Elongated oligomers in beta2-microglobulin
amyloid assembly revealed by ionmobility spectrometry-mass spectrometry, Proc.
Natl. Acad. Sci. U. S. A. 107 (15) (2010) 6794–6798.
[110] Z. Ahdash, E. Pyle, A. Politis, Hybrid mass spectrometry: towards characterization
of protein conformational states, Trends Biochem. Sci. 41 (8) (2016) 650–653.
[111] V. Katta, B.T. Chait, Conformational changes in proteins probed by hydrogen-ex-
change electrospray-ionization mass spectrometry, Rapid Commun. Mass
Spectrom. 5 (4) (1991) 214–217.
[112] T.E. Wales, J.R. Engen, Hydrogen exchange mass spectrometry for the analysis of
protein dynamics, Mass Spectrom. Rev. 25 (1) (2006) 158–170.
[113] J. Floege, et al., Clearance and synthesis rates of beta 2-microglobulin in patients
undergoing hemodialysis and in normal subjects, J. Lab. Clin. Med. 118 (2)
(1991) 153–165.
[114] H. Cole, et al., Early stages of insulin ﬁbrillogenesis examined with ion mobility
mass spectrometry andmolecular modelling, Analyst 140 (20) (2015) 7000–7011.
[115] J.L. Jimenez, et al., The protoﬁlament structure of insulin amyloid ﬁbrils, Proc. Natl.
Acad. Sci. U. S. A. 99 (14) (2002) 9196–9201.
8 A. Politis, C. Schmidt / Journal of Proteomics xxx (2017) xxx–xxx
Please cite this article as: A. Politis, C. Schmidt, Structural characterisation of medically relevant protein assemblies by integrating mass
spectrometry with computational modelling, J Prot (2017), http://dx.doi.org/10.1016/j.jprot.2017.04.019
